loader
Please Wait
Applying Filters...

Evonik Evonik

X

List of Cilastatin Sodium NDC API suppliers/manufacturers & exporters

Client Email Product
Menu
Filters Filter
Cross PopUp
FILTER :

filter

01 ACS DOBFAR SPA (1)

02 Merck Sharp & Dohme Corp. (1)

filter

01 CILASTATIN SODIUM (1)

02 Cilastatin Sodium (1)

filter

01 Italy (1)

02 U.S.A (1)

URL Supplier Web Content
Cilastatin Sodium
POWDER (1kg/kg)
BULK INGREDIENT
52946-0928
2022-10-07
2024-12-31
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
CILASTATIN SODIUM
POWDER (1kg/kg)
EXPORT ONLY
69806-0094
2015-08-24
2024-12-31
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Looking for 81129-83-1 / Cilastatin Sodium API manufacturers, exporters & distributors?

Cilastatin Sodium manufacturers, exporters & distributors 1

41

PharmaCompass offers a list of Cilastatin Sodium API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Cilastatin Sodium manufacturer or Cilastatin Sodium supplier for your needs.

Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Cilastatin Sodium manufacturer or Cilastatin Sodium supplier.

PharmaCompass also assists you with knowing the Cilastatin Sodium API Price utilized in the formulation of products. Cilastatin Sodium API Price is not always fixed or binding as the Cilastatin Sodium Price is obtained through a variety of data sources. The Cilastatin Sodium Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.

API | Excipient name

Cilastatin Sodium

Synonyms

81129-83-1, Cilastatin sodium salt, Cilastatin na, Mls001401364, Sodium;(z)-7-[(2r)-2-amino-2-carboxyethyl]sulfanyl-2-[[(1s)-2,2-dimethylcyclopropanecarbonyl]amino]hept-2-enoate, Mk-791

Cas Number

81129-83-1

About Cilastatin Sodium

A renal dehydropeptidase-I and leukotriene D4 dipeptidase inhibitor. Since the antibiotic, IMIPENEM, is hydrolyzed by dehydropeptidase-I, which resides in the brush border of the renal tubule, cilastatin is administered with imipenem to increase its effectiveness. The drug also inhibits the metabolism of leukotriene D4 to leukotriene E4.

Cilastatin Sodium Manufacturers

A Cilastatin Sodium manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Cilastatin Sodium, including repackagers and relabelers. The FDA regulates Cilastatin Sodium manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Cilastatin Sodium API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

click here to find a list of Cilastatin Sodium manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.

Cilastatin Sodium Suppliers

A Cilastatin Sodium supplier is an individual or a company that provides Cilastatin Sodium active pharmaceutical ingredient (API) or Cilastatin Sodium finished formulations upon request. The Cilastatin Sodium suppliers may include Cilastatin Sodium API manufacturers, exporters, distributors and traders.

click here to find a list of Cilastatin Sodium suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.

Cilastatin Sodium NDC

National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Cilastatin Sodium as an active pharmaceutical ingredient (API).

Finished drug products

The FDA updates the NDC directory daily. The NDC numbers for Cilastatin Sodium API and other APIs are published in this directory by the FDA.

Unfinished drugs

The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.

Pharmaceutical companies that manufacture Cilastatin Sodium as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.

Compounded drug products

The NDC directory also contains data on finished compounded human drug products that contain Cilastatin Sodium and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Cilastatin Sodium NDC to their finished compounded human drug products, they may choose to do so.

click here to find a list of Cilastatin Sodium suppliers with NDC on PharmaCompass.

Cilastatin Sodium Manufacturers | Traders | Suppliers

Cilastatin Sodium Manufacturers, Traders, Suppliers 1
28

We have 2 companies offering Cilastatin Sodium

Get in contact with the supplier of your choice:

  1. ACS DOBFAR SPA
  2. Merck & Co
Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.
Post Enquiry
POST ENQUIRY